G Medical Innovations Holdings Limited Return on Equity

G Medical Innovations Holdings Limited (GMVD) currently reports a ROE of -81.78%. That is below the Healthcare sector average of 21.28%. Use the charts on this page to explore G Medical Innovations Holdings Limited's ROE history and peer comparisons.

G Medical Innovations Holdings Limited's ROE of -81.78% is lower than the Healthcare sector average of 21.28%. That is roughly 484.3% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but G Medical Innovations Holdings Limited's current -81.78% should be judged against Healthcare norms (sector average: 21.28%) and against GMVD's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of -81.78%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 21.28%. From there, open related valuation or income-statement pages for G Medical Innovations Holdings Limited, and consider following GMVD for alerts when major investors trade the stock.

G Medical Innovations Holdings Limited is classified in the Healthcare sector. On ROE, it currently shows -81.78% versus a sector average near 21.28%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing GMVD with unrelated industries.